Clinical trial
Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular…
NCT00188812 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00188812 |
|---|---|
| Title | Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease |
| Official title | Open-Label, Multicentre, One Year Extension of the Evaluation of the Safety of Donepezil Hcl in Patients With Dementia Associated With Cerebrovascular Disease |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Eisai Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dementia Associated With Cerebrovascular Disease |
| Intervention type | Drug |
| Interventions | donepezil hcl |
| Start date | May 1, 2004 |
| Completion | Aug 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Jan 12, 2009 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: